DR SCOTT Gottlieb has been named as the new leader of the US Food and Drug Administration.
President Donald Trump has tasked Dr Gottlieb with the goal of cutting red tape at the FDA, describing the organisation's drug approval processes as "slow and burdensome" despite changes to speed reviews, particularly of cutting-edge products.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 17
